Putin tests experimental nasal vaccine against COVID-19


PTI, Nov 25, 2021, 9:11 AM IST

Moscow: President Vladimir Putin said Wednesday he has taken an experimental nasal vaccine against the coronavirus, three days after he received his booster shot.

Russia is facing its worst surge of infections and deaths since the pandemic began and is struggling to overcome widespread vaccine hesitancy.

Putin was vaccinated with Sputnik V, Russia’s domestically developed COVID-19 vaccine, in the spring. On Sunday, he said he received a booster shot of Sputnik Light, the one-dose version of the jab, and said he wanted to take part in testing the nasal version of Sputnik V.

Denis Logunov, deputy director of Russia’s state-funded Gamaleya Center that developed Sputnik V, told Putin on Sunday the nasal vaccine is yet to go through clinical studies and is currently being tested “off-label mostly” — on the centre’s staff members.

In accordance with established scientific protocols, the vaccine will need to go through several trial phases, including those involving thousands of people, to establish that it is safe and effective to use.

Last month, Russia’s Health Ministry gave a regulatory go-ahead to early trials of the nasal form of Sputnik V among 500 volunteers, but it was not immediately clear whether it has already started.

Putin told a government meeting Wednesday that ”exactly six months after vaccination my titers of protective (antibodies) have dropped, and specialists recommended the procedure of revaccination, which I did.” He said he didn’t experience any unpleasant effects after taking the nasal vaccine.

In recent weeks, Russia has been swept by its highest ever COVID-19 surge, with officials regularly registering record-high numbers of new infections and deaths.

The surge came amid low vaccination rates and lax public attitudes toward taking precautions. Fewer than 40% of Russia’s nearly 146 million people have been fully vaccinated, even though the country approved a domestically developed COVID-19 vaccine months before most of the world.

Russians are currently offered four domestically developed vaccines, with Sputnik V and Sputnik Light dominating the market. Data on efficacy of two other ones, EpiVacCorona and CoviVac, is yet to be released; just like Sputnik V, these two shots have been given regulatory approval before completing late-stage trials necessary to establish their effectiveness in preventing disease.

Russia’s Health Ministry is expected to approve a version of Sputnik V for teenagers aged 12 to 17 on Wednesday, Deputy Prime Minister Tatyana Golikova told Putin during the government meeting.

According to Russia’s state registry of clinical trials, the jab, which is in essence a smaller dose of Sputnik V, was being tested on more than 3,600 volunteers. No data on its efficacy has been released yet.

The immunisation drive in Russia has been hampered by widespread vaccine hesitancy. A poll released by the independent pollster Levada Center earlier this month showed that 45% of Russians weren’t willing to get domestically developed shots.

In an effort to boost vaccine uptake, doctors from 11 Russian hospitals released an open letter Wednesday, inviting those sceptical of vaccines — and a number of prominent public figures in particular who are known to air their scepticism in public — to visit coronavirus wards and intensive care units with COVID-19 patients.

“Maybe after that you’ll change your mind and fewer people will be dying,” the letter read.

Russia’s state coronavirus task force reported 33,558 new infections on Wednesday and 1,240 deaths. Golikova called the daily mortality numbers “dramatic”, noting at the same time that contagions in the country have taken a downward trend.

In total, the task force has reported over 9.4 million confirmed infections and more than 267,000 COVID-19 deaths, by far the highest death toll in Europe. Some experts believe the true figure is even higher.

Reports by Russia’s statistical service, Rosstat, that tally coronavirus-linked deaths retroactively, reveal much higher mortality. They say 462,000 people with COVID-19 died between April 2020 and September of this year.

Russian officials have said the task force only includes deaths for which COVID-19 was the main cause, and uses data from medical facilities. Rosstat uses wider criteria for counting virus-related deaths and takes its numbers from civil registry offices where registering a death is finalised.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Congress’ guarantees implemented in Karnataka amid BJP’s false propaganda: Shivakumar

Followers of Sanatan Dharma will respond to those disrespecting it: Pawan Kalyan

Pushpa bows down to no one, but will do so for you: Allu Arjun to fans at ‘Pushpa 2’ trailer launch

Magnus Magic in Kolkata: Carlsen completes double in style

Actor-singer held with MDMA, ganja

Truth coming out: PM Modi on movie on Godhra train burning

Only ineligible BPL cards will be weeded out, no impact on eligible cardholders: K’taka CM

Related Articles More

World Diabetes Day 2024: Kasturba Hospital Manipal Hosts Zumba Session at Malpe Beach to Raise Diabetes Awareness

World Diabetes Day: An overview of types of diabetes

World Diabetes Day: One-fourth of people living with diabetes in 2022 are in India, Lancet study estimates

Disruption in liver-brain communication behind overeating, Study claims

Acute Blood Shortage at Kasturba Hospital, Manipal: Donate blood and save lives

MUST WATCH

Swimming pool

| ₹50 LAKH SEIZED FROM TIRE |

New Technology In Kambala

Lakshdeepotsava 2024 Shree Krishna Mutt

Punganur Cow


Latest Additions

Congress’ guarantees implemented in Karnataka amid BJP’s false propaganda: Shivakumar

Followers of Sanatan Dharma will respond to those disrespecting it: Pawan Kalyan

Pushpa bows down to no one, but will do so for you: Allu Arjun to fans at ‘Pushpa 2’ trailer launch

Priyanka Gandhi leads roadshow in Nagpur

Sport teaches values beyond competition: Srihari Nataraj

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.